SI1425033T1 - Uporaba hcg in lh pri kontrolirani ovarijski hiperstimulaciji - Google Patents

Uporaba hcg in lh pri kontrolirani ovarijski hiperstimulaciji

Info

Publication number
SI1425033T1
SI1425033T1 SI200230927T SI200230927T SI1425033T1 SI 1425033 T1 SI1425033 T1 SI 1425033T1 SI 200230927 T SI200230927 T SI 200230927T SI 200230927 T SI200230927 T SI 200230927T SI 1425033 T1 SI1425033 T1 SI 1425033T1
Authority
SI
Slovenia
Prior art keywords
hcg
ovarian hyperstimulation
controlled ovarian
controlled
hyperstimulation
Prior art date
Application number
SI200230927T
Other languages
English (en)
Inventor
Yves Menezo
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182262&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1425033(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of SI1425033T1 publication Critical patent/SI1425033T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SI200230927T 2001-09-12 2002-09-12 Uporaba hcg in lh pri kontrolirani ovarijski hiperstimulaciji SI1425033T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01307758 2001-09-12
PCT/GB2002/004167 WO2003022303A2 (en) 2001-09-12 2002-09-12 Use of hcg and lh in controlled ovarian hyperstimulation
EP02758602A EP1425033B1 (en) 2001-09-12 2002-09-12 Use of hcg and lh in controlled ovarian hyperstimulation

Publications (1)

Publication Number Publication Date
SI1425033T1 true SI1425033T1 (sl) 2011-01-31

Family

ID=8182262

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230927T SI1425033T1 (sl) 2001-09-12 2002-09-12 Uporaba hcg in lh pri kontrolirani ovarijski hiperstimulaciji

Country Status (27)

Country Link
US (1) US7402558B2 (sl)
EP (1) EP1425033B1 (sl)
JP (1) JP2005501919A (sl)
KR (1) KR20040032952A (sl)
CN (1) CN100376289C (sl)
AR (1) AR036593A1 (sl)
AT (1) ATE489964T1 (sl)
BR (1) BR0212447A (sl)
CA (1) CA2457851A1 (sl)
CY (1) CY1110991T1 (sl)
DE (1) DE60238490D1 (sl)
DK (1) DK1425033T3 (sl)
EA (1) EA009279B1 (sl)
ES (1) ES2356895T3 (sl)
HK (1) HK1067865A1 (sl)
HR (1) HRP20040086A2 (sl)
IL (1) IL160782A0 (sl)
ME (1) MEP38708A (sl)
MX (1) MXPA04002257A (sl)
NO (1) NO327153B1 (sl)
PL (1) PL369021A1 (sl)
PT (1) PT1425033E (sl)
SI (1) SI1425033T1 (sl)
UA (1) UA82052C2 (sl)
WO (1) WO2003022303A2 (sl)
YU (1) YU21104A (sl)
ZA (1) ZA200400781B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
GB0723882D0 (en) * 2007-12-07 2008-01-23 Univ Leicester Methods for the detection of a threatened miscarriage
KR20140053991A (ko) * 2011-07-18 2014-05-08 아츠 바이올로직스 에이/에스 장기간 작용하는 황체 형성 호르몬 (ｌｈ) 화합물
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
EP3037101B1 (en) * 2014-12-22 2019-03-06 Ferring B.V. Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
PL3261661T3 (pl) 2015-02-26 2024-03-25 Ferring B.V. Menotropina do leczenia niepłodności
WO2017192847A1 (en) * 2016-05-04 2017-11-09 University Of Cincinnati Female fertility therapies
CA3110205A1 (en) * 2018-10-17 2020-04-23 Ferring Bv Compositions and methods for controlled ovarian stimulation
CN110041436A (zh) * 2019-04-28 2019-07-23 广州威生医药科技有限公司 长效重组fsh融合蛋白在母猪批次化生产中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US5705478A (en) 1989-02-21 1998-01-06 Washington University Covalently linked β subunits of the glycoprotein hormones as antagonists
FR2744367B1 (fr) * 1996-02-02 1999-07-09 Emperaire Jean Claude Medicaments pour le declenchement de l'ovulation
EP0994718B1 (en) * 1997-06-20 2005-08-17 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
ZA987497B (en) 1997-09-08 1999-02-23 Akzo Nobel Nv Expression of gonadotropins in dictyostelium
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
BR0008468A (pt) 1999-02-24 2002-02-05 Novo Nordisk As Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos
ATE332705T1 (de) * 1999-05-07 2006-08-15 Applied Research Systems Verwendung von in der mittlere oder späte follikuläre phase verabreichte lh zur behandlung von anovulatorischen frauen
BR0107881A (pt) 2000-01-27 2003-04-01 Applied Research Systems Uso de fsh tratamento de infertilidade
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation

Also Published As

Publication number Publication date
MEP38708A (en) 2011-02-10
DK1425033T3 (da) 2011-01-10
AR036593A1 (es) 2004-09-22
US7402558B2 (en) 2008-07-22
UA82052C2 (uk) 2008-03-11
EP1425033A2 (en) 2004-06-09
WO2003022303A3 (en) 2003-12-18
ES2356895T3 (es) 2011-04-14
CN100376289C (zh) 2008-03-26
ZA200400781B (en) 2005-04-26
ATE489964T1 (de) 2010-12-15
YU21104A (sh) 2006-08-17
JP2005501919A (ja) 2005-01-20
HRP20040086A2 (en) 2004-12-31
MXPA04002257A (es) 2004-07-23
EA200400426A1 (ru) 2004-08-26
CN1553810A (zh) 2004-12-08
IL160782A0 (en) 2004-08-31
US20050020489A1 (en) 2005-01-27
PT1425033E (pt) 2010-12-29
PL369021A1 (en) 2005-04-18
HK1067865A1 (en) 2005-04-22
KR20040032952A (ko) 2004-04-17
CY1110991T1 (el) 2015-06-11
DE60238490D1 (de) 2011-01-13
CA2457851A1 (en) 2003-03-20
EP1425033B1 (en) 2010-12-01
BR0212447A (pt) 2004-08-17
EA009279B1 (ru) 2007-12-28
NO327153B1 (no) 2009-05-04
NO20040962L (no) 2004-03-05
WO2003022303A2 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
HK1067867A1 (en) Use of hcg in controlled ovarian hyperstimulation
EP1367687A4 (en) BATTERY-POWERED ELECTRONIC DEVICE AND METHOD OF CONTROLLING THE SAME
HK1067866A1 (en) Use of lh in controlled ovarian hyperstimulation
HK1062457A1 (en) Modified and stabilized gdf propeptides and uses thereof
HK1084127A1 (en) Recombinant anti-osteopontin antibody and use thereof
PL369855A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
PL366469A1 (en) Anti-osteopontin antibody and use thereof
AU2003300421A8 (en) Rfid device and method of forming
PL375390A1 (en) 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines
GB2378574B (en) Improvements in and relating to piezo-active devices
EP1368051A4 (en) UROCORTINE III AND SOME OF ITS USES
SI1425033T1 (sl) Uporaba hcg in lh pri kontrolirani ovarijski hiperstimulaciji
GB2394359B (en) Microelctronic device and method of its manufacture
EP1367123A4 (en) NEUROTONIN AND ITS USE
GB0126083D0 (en) Improvements in and relating to optoelectronic devices
GB2377179B (en) Magnotherapy device and use thereof
GB0130594D0 (en) Improvements in and relating to bath screens
TW493609U (en) Moving and carrying device
AU2002367301A8 (en) Object lifting and moving device
GB0105812D0 (en) Improvements in and relating to control of electrically controlled articles
GB0119626D0 (en) Improvements in and relating to object handling devices
GB0127328D0 (en) Growth hormone variations in humans and their uses
EP1437367A4 (en) ANTIBODIES AND ITS USE
GB2378579B (en) Improvements in and relating to latching mechanisms
GB0123575D0 (en) Doors and components therof